Clinical Trials Logo

Filter by:
NCT ID: NCT03656055 Completed - Multiple Sclerosis Clinical Trials

Analysis of Neurodegenerative Process Within Visual Ways In Multiple Sclerosis

VWIMS
Start date: April 21, 2017
Phase:
Study type: Observational

This study will interest in the pathophysiology of silent retinal axonal loss in multiple sclerosis. Recent studies have suggested that silent retinal axonal loss (no past history of optic neuritis [ON]) may be due to inflammatory lesions within the optic radiations and a transsynaptic degenerative process. The objective is to measure the exact role of silent optic nerve lesion in the occurrence of silent retinal axonal loss by performing OCT, brain and optic nerve MRI in a cohort of patients without recent disease activity.

NCT ID: NCT03655730 Completed - Depressive Symptoms Clinical Trials

Efficacity of Psychological Intervention on Reducing the Suicidal Ideations, Depression Level and Improving Reinsertion

MLADO
Start date: December 3, 2018
Phase: N/A
Study type: Interventional

Suicide is the third leading cause of death in adolescents and young adults in the United States and the second leading cause in European countries. Depressive disorders are consistently the most prevalent psychiatric disorder among adolescents who attempt suicide with a prevalence ranging from 49% to 64%. Depression in adolescent and young adults is a multifactorial phenomenon, as is the risk of suicidal attempt. To address such problems, effective and accessible treatment is needed, as recommended by the French Health Authority (HAS). Our primary objective is to demonstrate that a weekly psychotherapeutic intervention reduces the depression level. The primary assessment criterion is the variation of the clinician Adolescent Depression Rating Scale (ADRSc) from randomisation to month 6. The study also aims comparing in the 2 randomised groups - ADRS depression global score (clinician and subject) at 0, 3, 9 and 12 months - Number of suicidal attempts and self-harm attempts at 6 and 12 months - Number of drop-out at 6 and 12 months - Beck's Hopelessness Scale at 0, 3, 6, 9 and 12 months - Global score on the GHQ-28 and scores on the 4 subscales (Somatization, Anxiety and Insomnia, Social dysfunction, Depressive mood) at 0, 3, 6, 9 and 12 months. - Working AIliance Inventory (WAI) score at 0, 3, 6, 9 and 12 months

NCT ID: NCT03655340 Completed - Haemophilia B Clinical Trials

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

B-SURE
Start date: September 12, 2018
Phase:
Study type: Observational

Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor product. The purpose of this non-interventional study is to describe the real-world usage and effectiveness of Alprolix in the on-demand and prophylactic treatment of haemophilia B.

NCT ID: NCT03655093 Completed - Multiple Sclerosis Clinical Trials

Validation of a Self-questionnaire in French on the Use of the Upper Limbs in Patients With Multiple Sclerosis

MS-SEP
Start date: April 25, 2017
Phase:
Study type: Observational

Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system that causes disability in young adults. This disability can take many forms depending on the neurological systems affected: disability walking, cognitive impairment or disability in the upper limbs. The development of validated measurement tools for these different disabilities is essential for the follow-up of patients in clinical routine and for the evaluation of new therapies.

NCT ID: NCT03654976 Completed - Clinical trials for Allergic Rhinitis Due to House Dust Mite

Mite Asthma Pediatric Immunotherapy Trial

MAPIT
Start date: February 22, 2018
Phase: Phase 3
Study type: Interventional

The trial aims to demonstrate efficacy of the House Dust Mite SLIT-tablet versus placebo as add-on treatment in children and adolescents (5-17 years) with House Dust Mite allergic asthma based on clinically relevant asthma worsening.

NCT ID: NCT03654794 Completed - Hemochromatosis Clinical Trials

Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells

DIFF-TAC
Start date: October 24, 2013
Phase:
Study type: Observational

Pharmacokinetics of tacrolimus are highly variable and may result in graft rejection (underdosing) or toxicity (overdosing). The risk of transplant rejection and the toxicity of tacrolimus can be reduced by pharmacological therapeutic monitoring of the molecule, based on the measurement of residual blood concentrations. Nevertheless, some patients are victims of rejections or toxic signs even though their blood concentrations are in the therapeutic target. The aim of the study is to describe the pharmacokinetics of tacrolimus diffusion in mononuclear cells as well as the kinetics of effect of the drug on its target protein

NCT ID: NCT03654469 Completed - COPD Clinical Trials

Bronchial Obstruction in Dairy Farmers

BPCO Airbag
Start date: February 27, 2012
Phase:
Study type: Observational [Patient Registry]

Chronic Obstructive Pulmonary Disease (COPD) is a major public health problem and is expected to become the 3rd leading cause of death globally by 2020. The main risk factor is tobacco. Tobacco poisoning is found in 80 to 90% of patients with COPD. However, non-smoking COPD is also described, with increasing prevalence figures, particularly related to occupational exposure, especially among farmers.

NCT ID: NCT03654430 Completed - Healthy Clinical Trials

Study by 2D-strain of the Ventricular Wall Motion During Postnatal Adaptation

BABYSTRAIN
Start date: April 3, 2018
Phase: N/A
Study type: Interventional

The left ventricular torsion during systole and diastole is a normal dynamic mechanism which participates in the ejection and the filling of the left ventricle. Postnatal hemodynamic modifications are major and probably affect this mechanism. The aim of this study is to compare the left ventricular twist in healthy newborns, between their first days of life and their third month of life, using the 2D-speckle tracking echocardiography.

NCT ID: NCT03654118 Completed - Clinical trials for Recurrent Anterior Shoulder Instability

Long-term Review of a Cohort of Arthroscopic Bankart Interventions

ISIS-2017
Start date: August 7, 2017
Phase:
Study type: Observational

Recurrent instability is the most common chronic shoulder pathology of the young and athletic patient. It is a source of functional, sporting and professional disability, and a permanent apprehension to the use of the affected shoulder. Surgical treatment has been proposed for a long time by the reintegration of the labrum (intervention of Bankart) then by the making of an osteo-muscular stop (intervention of Latarjet). Like in many domains, surgical techniques have evaluated towards the search for endoscopic alternatives to open surgery, more deleterious. Bankart's intervention has been performed arthroscopically since the 1980s and remains the majority intervention in the United States. However, its success rate never reached that of open techniques, Bankart and Latarjet. Surgeons therefore sought the predictors of these failures in order to define the limits of the indications for arthroscopic Bankart intervention. The determination and use of the preoperative instability score (Instability Severity Index Score : ISIS) described by Balg and Boileau is one of the ways to clarify these indications. The aim of this study is to prospectively establish the values of the ISIS score to obtain an acceptable recurrence rate of long-term instability

NCT ID: NCT03653884 Completed - Clinical trials for Obstetric Complication

Intra-abdominal Umbilical Vein Aneurysm

AVO
Start date: January 22, 2018
Phase:
Study type: Observational

The purpose of this study is to investigate the ultrasound characteristics and outcome of pregnancies with fetal Intra-abdominal umbilical vein aneurysm.